Acquisition of CerpassRx by LucyRx Strengthens Clinical Quality and Increases Availability of Cutting-edge Healthcare Services
The technology-driven, next-generation pharmacy benefits manager (PBM), LucyRx, has announced a strategic acquisition of CerpassRx, a service-first PBM known for its cost containment expertise. This partnership combines LucyRx’s advanced clinical and technology-driven model with CerpassRx’s strong focus on service and cost management, creating a more efficient, transparent, and impactful prescription care solution.
This integration promises to deliver smarter care, stronger savings, and a seamless experience for clients and members.
Delivering Smarter Care
LucyRx’s proprietary Formulary Marketplace, Connected Specialty Care Network, and personalized clinical guidance will focus on high-impact therapies such as GLP-1 and Women’s Health. This will enable the company to provide tailored, evidence-based care to its clients and members.
Achieving Stronger Savings
CerpassRx excels in driving down prescription costs through its proprietary cost containment strategies, flexible formulary design, and tailored clinical programs. By integrating these strategies into the LucyRx platform, the combined entity aims to achieve significant savings for its clients and members.
Providing a Seamless Experience
The merger of CerpassRx’s high-touch service model with LucyRx’s technology scale and clinical approach will provide a seamless experience for clients and members. This will ensure that they receive personalized, efficient, and effective prescription care.
The acquisition is subject to regulatory approvals and customary closing conditions and is expected to close in Q3 2025. During this transition, there will be no changes to service, support, or operations for clients and members.
The combined entity, formed by the acquisition, will be a national PBM platform that is performance-driven, clinically forward, and relentlessly focused on serving clients and members with clarity and accountability. This partnership continues the work of both companies in reducing pharmacy costs for employers and their members, advancing a shared commitment to bring more transparency, innovation, and affordability to healthcare.
LucyRx, a fast-scaling, independent, next-generation PBM serving over 1,200 clients nationwide, is backed by Nomi Health, a direct healthcare company founded in 2019. Nomi Health's integrated platform combines analytics, direct provider networks, and real-time payment solutions. LucyRx's proprietary AI platform, LucyIQ™, provides real-time insights for evidence-based clinical decisions, clear pricing, and exceptional service.
Together, LucyRx and CerpassRx form a powerful team, poised to raise the standard for pharmacy benefit management by offering transparent, high-quality, and personalized prescription care while controlling costs effectively. This strategic partnership marks an exciting step forward in the evolution of pharmacy benefits management.
[1] LucyRx Press Release, [Date] [2] CerpassRx Press Release, [Date] [3] Nomi Health Press Release, [Date]
- The technology-driven approach of LucyRx's proprietary AI platform, LucyIQ™, promises to deliver exceptional service and real-time insights for evidence-based clinical decisions and clear pricing.
- LucyRx, backed by Nomi Health, is a fast-scaling, independent, next-generation PBM, serving over 1,200 clients nationwide, and is known for its advanced clinical and technology-driven model.
- The acquisition of CerpassRx by LucyRx is a strategic move that combines two performance-driven entities focused on reducing pharmacy costs for employers and their members.
- The new partnership between LucyRx and CerpassRx aims to bring more transparency, innovation, and affordability to healthcare, merging the high-touch service model of CerpassRx with LucyRx's technology scale and clinical approach.
- The integration of CerpassRx's cost containment strategies, such as its flexible formulary design and tailored clinical programs, into the LucyRx platform will allow for significant savings for clients and members.
- LucyRx's Formulary Marketplace, Connected Specialty Care Network, and personalized clinical guidance will focus on high-impact therapies such as GLP-1 and Women’s Health, providing tailored, evidence-based care to clients and members.
- The combination of LucyRx’s and CerpassRx’s expertise in areas such as health-and-wellness, fitness-and-exercise, and nutrition will lead to a more efficient and impactful prescription care solution.
- The acquisition of CerpassRx by LucyRx will also impact the finance sector, as the combined entity aims to provide personal-finance and business owners with transparent, high-quality, and personalized prescription care while controlling costs effectively.
- The partnership between LucyRx and CerpassRx is expected to redefine the landscape of the pharmacy benefits management industry, influencing news in the general-news and business sectors.
- This strategic partnership between LucyRx and CerpassRx represents not just a merger of businesses, but an alliance dedicated to improving the lives of clients and members, as they strive to promote a holistic, technology-driven lifestyle in various aspects such as science, education-and-self-development, home-and-garden, shopping, and even casino-and-gambling.
